Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …

Despite the high prevalence of obstructive sleep apnea (OSA) syndrome, no ideal therapy
has emerged to date. Based on recent randomized trials, continuous positive airway …

Background Continuous Positive Airways Pressure (CPAP) is considered to be the
cornerstone of therapy for obstructive sleep apnoea (OSA). However, compliance with this …

Background Continuous positive airway pressure (CPAP) is typically recommended as first
line therapy for obstructive sleep apnea, but the adherence rate of CPAP is problematic. This …

Background Previous studies have shown conflicting results on the effect of continuous
positive airway pressure (CPAP) on quality of life (QoL) in obstructive sleep apnoea (OSA) …

Objective Substantial research indicates a clear relationship between obstructive sleep
apnoea syndrome (OSAS) and depression. The study aim was to quantitatively evaluate …

Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Background The evidence base for the treatment of mild obstructive sleep apnoea is limited
and definitions of disease severity vary. The MERGE trial investigated the clinical …

Introduction: Obstructive sleep apnea (OSA) is a highly prevalent condition affecting persons
of all age with an increasing public health burden. It is implicated in cardiovascular disease …

Continuous positive airway pressure is the first-line and gold-standard treatment for
obstructive sleep apnea (OSA). Pharmacotherapy is not commonly used in treating OSA …